Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-26

FDA Approved: RAMELTEON — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved an original ANDA for ramelteon from Upsher-Smith Laboratories, enabling a generic ramelteon product to reach the market. Ramelteon is indicated for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)